Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018)
Baxter International (BAX) reported Non-Current Deferred Tax Liability of $205.0 million for Q4 2018, down 26.79% year-over-year from $280.0 million in Q4 2017, and down 26.79% quarter-over-quarter from $280.0 million in Q4 2017.
Baxter International (BAX) Non-Current Deferred Tax Liability (2014 - 2018) Analysis & Trends
Baxter International (BAX) has 5 years of Non-Current Deferred Tax Liability data on file, last reported at $205.0 million in Q4 2018.
- Non-Current Deferred Tax Liability for Q4 2018 came in at $205.0 million, down 26.79% year-over-year; the trailing twelve-month figure through Dec 2018 was $205.0 million (down 26.79% YoY), and the FY2018 annual result was $205.0 million, down 26.79% from the prior year.
- Non-Current Deferred Tax Liability slipped to $205.0 million in Q4 2018 per BAX's latest filing, from $280.0 million in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $280.0 million in Q4 2017 and troughed at $93.0 million in Q4 2016.
- A 5-year average of $188.2 million and a median of $195.0 million in 2015 frame the typical range for Non-Current Deferred Tax Liability.
- The sharpest annual moves came in 2016 and 2017: Non-Current Deferred Tax Liability slumped 52.31% in 2016, then jumped 201.08% in 2017.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $168.0 million in 2014, then grew by 16.07% to $195.0 million in 2015, then slumped by 52.31% to $93.0 million in 2016, then jumped by 201.08% to $280.0 million in 2017, then dropped by 26.79% to $205.0 million in 2018.
- Business Quant data shows BAX's Non-Current Deferred Tax Liability at $205.0 million in Q4 2018, $280.0 million in Q4 2017, and $93.0 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 205.00 Mn |
| Dec 31, 2018 | 205.00 Mn |
| Dec 31, 2017 | 280.00 Mn |
| Dec 31, 2017 | 280.00 Mn |
| Dec 31, 2016 | 93.00 Mn |
| Dec 31, 2016 | 93.00 Mn |
| Dec 31, 2015 | 195.00 Mn |
| Dec 31, 2015 | 195.00 Mn |
| Dec 31, 2014 | 168.00 Mn |
| Dec 31, 2014 | 168.00 Mn |